{"id":"a91431a1-b441-4e71-b7f6-fbf6277ef870","modelId":"0e2f5d6f-8ce6-4726-9301-d438ecf732bc","versionId":null,"locationId":"aa8b9c05-c836-4021-801f-59801970401e","operatorId":null,"ownerId":null,"slug":"intuitive-ion-us","status":"operational","firstSeen":"2019-06-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":null,"shiftStructure":null,"hoursPerDay":null,"siteType":null,"operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":null,"deploymentScale":null,"siteEnvironment":null,"operatorType":null,"sourceQualityTier":null,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.intuitive.com/en-us/products-and-services/ion","label":"Intuitive Ion robotic bronchoscopy system — product page"},{"url":"https://investors.intuitive.com/news-releases/news-release-details/intuitive-announces-fda-clearance-ion-endoluminal-system","label":"Intuitive: FDA clearance for Ion endoluminal system, 2019"}],"notes":"Ion Endoluminal System (Intuitive Surgical) operating in United States. Status: operational.","keyFacts":[],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-06-11T02:23:07.578Z","updatedAt":"2026-07-23T13:36:01.318Z","model":{"id":"0e2f5d6f-8ce6-4726-9301-d438ecf732bc","companyId":"e5127536-0ff2-4f0e-8488-64994cb2ffc7","modelName":"Ion Endoluminal System","slug":"intuitive-ion","description":"Intuitive Surgical's Ion Endoluminal System is a robotic-assisted bronchoscopy platform for minimally invasive biopsy of peripheral lung nodules. It uses an ultra-thin, shape-sensing maneuverable catheter with PlanPoint CT-based airway planning to reach lesions deep in the peripheral lung. FDA 510(k) cleared in February 2019 and commercially deployed across US hospitals, with subsequent AI and advanced-imaging integration clearances.","formFactor":"surgical","industryVertical":"healthcare","environment":"indoor","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{"pathway":"FDA 510(k) cleared 2019-02-20 (clearance number not corroborated to bar)","modality":"shape-sensing robotic-assisted bronchoscopy","planning":"PlanPoint CT-based airway planning","indication":"peripheral lung nodule biopsy"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://isrg.intuitive.com/news-releases/news-release-details/u-s-fda-grants-clearance-ion-intuitive/","title":"FDA grants clearance for Ion by Intuitive","sourceName":"Intuitive Surgical (official)"},{"url":"https://www.sages.org/publications/tavac/intuitive-ion-endoluminal-system/","title":"Ion Endoluminal System TAVAC","sourceName":"SAGES"}],"aliases":["Ion","Ion Endoluminal System"],"collisionRisk":"low","reviewNote":"Reviewed 2026-07-14: source-gated bulk flip (non-empty sources[]). Ben-approved.","manufacturerTermForTeleop":null,"keyFacts":[{"label":"FDA clearance","value":"FDA 510(k) cleared in February 2019"}],"createdAt":"2026-06-05T17:43:05.364Z","updatedAt":"2026-07-14T21:33:20.300Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"e5127536-0ff2-4f0e-8488-64994cb2ffc7","name":"Intuitive Surgical","slug":"intuitive-surgical","description":"Dominant surgical-robotics maker (NASDAQ: ISRG; founded 1995, Sunnyvale CA) of the [da Vinci](/models/intuitive-da-vinci) teleoperated surgical robots and the Ion robotic bronchoscopy system; 11,000+ da Vinci installed worldwide.","status":"public (NASDAQ: ISRG)","founded":1995,"hq":"Sunnyvale, California, USA","fundingTotal":null,"type":"both","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/0001035267/000103526726000032/isrg-20260331.htm","title":"Intuitive Form 10-Q (Q1 2026): 11,395 da Vinci installed (1,464 da Vinci 5); 1,041 Ion","sourceName":"SEC EDGAR"},{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000029/q126ex-991earningsrelease.htm","title":"Intuitive Q1 2026 earnings (procedures +17%; 431 da Vinci placed; revenue $2.77B)","sourceName":"SEC EDGAR"},{"url":"https://www.globenewswire.com/news-release/2024/03/14/2846718/7637/en/Intuitive-Announces-FDA-Clearance-of-Fifth-Generation-Robotic-System-da-Vinci-5.html","title":"Intuitive: FDA clearance of da Vinci 5 (510(k), Mar 14 2024; Force Feedback)","sourceName":"Intuitive (GlobeNewswire)"},{"url":"https://www.therobotreport.com/intuitive-demos-4000-mile-telesurgery-with-da-vinci-5-surgical-robot/","title":"Intuitive demos 4,000-mile telesurgery (investigational, in development)","sourceName":"The Robot Report"}],"keyFacts":[{"label":"Installed base","value":"11,395 da Vinci (1,464 da Vinci 5) + 1,041 Ion (SEC 10-Q, Q1 2026)."},{"label":"Gating events","value":"da Vinci 5 FDA-cleared Mar 14 2024; Ion FDA-cleared Feb 2019."},{"label":"Stock listing","value":"NASDAQ: ISRG"},{"label":"Market position","value":"Dominant surgical-robotics maker"},{"label":"da Vinci product type","value":"Teleoperated surgical robot"},{"label":"Ion product type","value":"Robotic bronchoscopy system"},{"label":"Hero image candidate","value":"https://upload.wikimedia.org/wikipedia/commons/7/77/New_Da_Vinci_Xi.jpg (source: Wikimedia Commons, license: CC BY-SA 4.0)"}],"aliases":["Intuitive","ISRG","da Vinci","Intuitive Surgical Inc","da Vinci robot","da Vinci surgical system"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"ISRG","stockExchange":"NASDAQ","secCik":"0001035267","revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-03T20:11:59.344Z","updatedAt":"2026-07-22T17:17:57.097Z"}},"version":null,"location":{"id":"aa8b9c05-c836-4021-801f-59801970401e","name":"United States","slug":"united-states","kind":"country","parentLocationId":null,"region":null,"lat":37.0902,"lng":-95.7129,"reviewStatus":"reviewed","aliases":["USA","US","United States of America"],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-05-30T22:00:33.148Z","updatedAt":"2026-07-04T13:32:31.997Z"},"operator":null,"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/intuitive-ion-us","url":"https://registry.deploy.report/deployments/intuitive-ion-us","name":"Ion Endoluminal System at United States","identifier":"a91431a1-b441-4e71-b7f6-fbf6277ef870","startDate":"2019-06-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/united-states","name":"United States"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/intuitive-surgical","name":"Intuitive Surgical"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/intuitive-ion","name":"Ion Endoluminal System"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":2,"primary_source_types":["primary-company-ir"]}}}